Noxopharm Limited (NOX.AX)

AUD 0.08

(2.67%)

Operating Expenses Summary of Noxopharm Limited

  • Noxopharm Limited's latest annual operating expenses in 2024 was 7 Million AUD , down -57.42% from previous year.
  • Noxopharm Limited's latest quarterly operating expenses in 2024 FY was 7 Million AUD , down -57.42% from previous quarter.
  • Noxopharm Limited reported a annual operating expenses of 16.44 Million AUD in annual operating expenses 2023, up 10.0% from previous year.
  • Noxopharm Limited reported a annual operating expenses of 14.94 Million AUD in annual operating expenses 2022, up 4.17% from previous year.
  • Noxopharm Limited reported a quarterly operating expenses of 3.53 Million AUD for 2024 Q4, down 0.0% from previous quarter.
  • Noxopharm Limited reported a quarterly operating expenses of 3.46 Million AUD for 2024 Q2, down 0.0% from previous quarter.

Annual Operating Expenses Chart of Noxopharm Limited (2024 - 2016)

Historical Annual Operating Expenses of Noxopharm Limited (2024 - 2016)

Year Operating Expenses Operating Expenses Growth
2024 7 Million AUD -57.42%
2023 16.44 Million AUD 10.0%
2022 14.94 Million AUD 4.17%
2021 14.34 Million AUD -11.02%
2020 16.12 Million AUD 3.34%
2019 15.6 Million AUD 49.44%
2018 10.44 Million AUD 222.31%
2017 3.23 Million AUD 363.0%
2016 699.72 Thousand AUD 0.0%

Peer Operating Expenses Comparison of Noxopharm Limited

Name Operating Expenses Operating Expenses Difference
AdAlta Limited 6.76 Million AUD -3.408%
Acrux Limited 8.55 Million AUD 18.126%
Actinogen Medical Limited 22.77 Million AUD 69.258%
AnteoTech Limited 12.18 Million AUD 42.56%
Argenica Therapeutics Limited 8.26 Million AUD 15.346%
Arovella Therapeutics Limited 10.78 Million AUD 35.095%
Anatara Lifesciences Ltd 710.21 Thousand AUD -885.641%
Alterity Therapeutics Limited 23.4 Million AUD 70.093%
Amplia Therapeutics Limited 8.43 Million AUD 17.017%
Avecho Biotechnology Limited 4.54 Million AUD -54.006%
Bio-Gene Technology Limited 2.76 Million AUD -153.537%
Biome Australia Limited 7.91 Million AUD 11.516%
Biotron Limited 5.11 Million AUD -36.972%
Botanix Pharmaceuticals Limited 601.82 Thousand AUD -1063.17%
BTC Health Limited -1.03 Million AUD 773.79%
Chimeric Therapeutics Limited 19.76 Million AUD 64.587%
CSL Limited 7.56 Billion AUD 99.907%
Clarity Pharmaceuticals Ltd 56.3 Million AUD 87.568%
Clinuvel Pharmaceuticals Limited 31.29 Million AUD 77.633%
Cynata Therapeutics Limited 11.12 Million AUD 37.069%
Dimerix Limited 25.64 Million AUD 72.702%
EZZ Life Science Holdings Limited 39.57 Million AUD 82.311%
Hexima Limited 1 Million AUD -593.947%
Island Pharmaceuticals Limited 4.12 Million AUD -69.687%
Immuron Limited 9.13 Million AUD 23.394%
Immutep Limited 42.87 Million AUD 83.673%
Imugene Limited 135.09 Million AUD 94.818%
Invex Therapeutics Ltd 3.34 Million AUD -109.218%
Memphasys Limited 3.67 Million AUD -90.306%
Nanollose Limited 12.5 Thousand AUD -55897.048%
Neuren Pharmaceuticals Limited 32.69 Million AUD 78.591%
NeuroScientific Biopharmaceuticals Limited 1.96 Million AUD -256.204%
Nyrada Inc. 4.55 Million AUD -53.676%
Orthocell Limited 15.36 Million AUD 54.454%
PharmAust Limited 6.65 Million AUD -5.156%
Patrys Limited 4.93 Million AUD -41.896%
Paradigm Biopharmaceuticals Limited 65.1 Million AUD 89.248%
Proteomics International Laboratories Limited 892.14 Thousand AUD -684.649%
Prescient Therapeutics Limited 10.89 Million AUD 35.771%
PYC Therapeutics Limited 60.91 Million AUD 88.509%
Race Oncology Limited 14.77 Million AUD 52.607%
Radiopharm Theranostics Limited 299.22 Thousand AUD -2239.417%
Recce Pharmaceuticals Ltd 21.68 Million AUD 67.718%
Starpharma Holdings Limited 22.81 Million AUD 69.319%
Telix Pharmaceuticals Limited 269.26 Million AUD 97.4%
Tissue Repair Ltd 6.66 Million AUD -5.001%
Zelira Therapeutics Limited 5.94 Million AUD -17.68%